EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Behavior of α-Synuclein Is Associated with Membrane Transport, Lipid Metabolism, and Ubiquitin–Proteasome Pathways in Lewy Body Disease

Tomoya Kon, Seojin Lee, Ivan Martinez-Valbuena iD, Koji Yoshida iD, Satoshi Tanikawa, Anthony E Lang, Gabor G Kovacs iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25052676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Tomoya Kon und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, 60 Leonard Ave., Toronto, ON M5T 0S8, Canada. Hauptthemen laut MEDLINE: alpha-Synuclein, Lewy Body Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rossy Family Foundation, Edmond J. Safra Philanthropic Foundation, Canada Foundation for Innovation John Evans Leaders Fund program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lewy body diseases (LBDs) feature α-synuclein (α-syn)-containing Lewy bodies, with misfolded α-syn potentially propagating as seeds. Using a seeding amplification assay, we previously reported distinct α-syn seeding in LBD cases based on the area under seeding curves. This study revealed that LBD cases showing different α-syn seeding kinetics have distinct proteomics profiles, emphasizing disruptions in mitochondria and lipid metabolism in high-seeder cases. Though the mechanisms underlying LBD development are intricate, the factors influencing α-syn seeding activity remain elusive. To address this and complement our previous findings, we conducted targeted transcriptome analyses in the substantia nigra using the nanoString nCounter assay together with histopathological evaluations in high (n = 4) and low (n = 3) nigral α-syn seeders. Neuropathological findings (particularly the substantia nigra) were consistent between these groups and were characterized by neocortical LBD associated with Alzheimer’s disease neuropathologic change. Among the 1811 genes assessed, we identified the top 20 upregulated and downregulated genes and pathways in α-syn high seeders compared with low seeders. Notably, alterations were observed in genes and pathways related to transmembrane transporters, lipid metabolism, and the ubiquitin–proteasome system in the high α-syn seeders. In conclusion, our findings suggest that the molecular behavior of α-syn is the driving force in the neurodegenerative process affecting the substantia nigra through these identified pathways. These insights highlight their potential as therapeutic targets for attenuating LBD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinLewy Body DiseaseHumansProteasome Endopeptidase ComplexLipid MetabolismUbiquitins

Stichwörter der Autor:innen

Lewy body diseaseParkinson’s diseasealpha-synucleinlipid metabolismmRNAnanoStringseeding capacitytranscriptometransmembrane transporterubiquitin

Substanzen

alpha-SynucleinProteasome Endopeptidase ComplexUbiquitins

Autor:innen und Institutionen

  • Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, 60 Leonard Ave., Toronto, ON M5T 0S8, Canada.
  • Department of Neurology, Hirosaki University Graduate School of Medicine, 5 Zaifu, Hirosaki 036-8562, Japan.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, 200 Elizabeth St., Toronto, ON M5G 2C4, Canada.
  • Department of Legal Medicine, Faculty of Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
  • Edmond J Safra Program in Parkinson's Disease and Rossy Progressive Supranuclear Palsy Centre, Toronto Western Hospital, 399 Bathurst St., Toronto, ON M5T 2S8, Canada.
  • Laboratory Medicine Program, University Health Network, 200 Elizabeth St., Toronto, ON M5G 2C4, Canada.

ORCID-Profile: Ivan Martinez-Valbuena, Koji Yoshida, Gabor G Kovacs

Förderung

  • Rossy Family Foundation
  • Edmond J. Safra Philanthropic Foundation
  • Canada Foundation for Innovation John Evans Leaders Fund program
  • Ontario Research Fund

Zitieren

APA

Kon, T., Lee, S., Martinez-Valbuena, I., Yoshida, K., Tanikawa, S., Lang, A. E., & Kovacs, G. G. (2024). Molecular Behavior of α-Synuclein Is Associated with Membrane Transport, Lipid Metabolism, and Ubiquitin–Proteasome Pathways in Lewy Body Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052676

Vancouver

Kon T, Lee S, Martinez-Valbuena I, Yoshida K, Tanikawa S, Lang AE, et al. Molecular Behavior of α-Synuclein Is Associated with Membrane Transport, Lipid Metabolism, and Ubiquitin–Proteasome Pathways in Lewy Body Disease. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052676

BibTeX
@article{Kon2024,
  author = {Kon, Tomoya and Lee, Seojin and Martinez-Valbuena, Ivan and Yoshida, Koji and Tanikawa, Satoshi and Lang, Anthony E and Kovacs, Gabor G},
  title = {Molecular Behavior of α-Synuclein Is Associated with Membrane Transport, Lipid Metabolism, and Ubiquitin–Proteasome Pathways in Lewy Body Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25052676}
}
Kostenlos starten →